A Study of Olanzapine in Patients With Acute Agitation
Status:
Not yet recruiting
Trial end date:
2024-07-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of intramuscular olanzapine
for the treatment of acute agitation associated with schizophrenia and bipolar I mania.